In a filing, Soleno Therapeutics Inc revealed its insider Hirano Patricia C unloaded Company’s shares for reported $0.32 million on Jul 01 ’25. In the deal valued at $82.76 per share,3,830 shares were sold. As a result of this transaction, Hirano Patricia C now holds 13,206 shares worth roughly $1.13 million.
Then, PATRICIA HIRANO bought 3,830 shares, generating $316,971 in total proceeds.
Before that, Hirano Patricia C sold 266 shares. Soleno Therapeutics Inc shares valued at $22,410 were divested by the insider at a price of $84.25 per share. As a result of the transaction, Hirano Patricia C now holds 17,036 shares, worth roughly $1.45 million.
TD Cowen initiated its Soleno Therapeutics Inc [SLNO] rating to a Buy in a research note published on June 23, 2025; the price target was $110. Stifel also remained covering SLNO and reiterated its “Buy” recommendation on December 02, 2024. Robert W. Baird maintained its rating on December 02, 2024. It rated SLNO as “an Outperform”.
Price Performance Review of SLNO
On Monday, Soleno Therapeutics Inc [NASDAQ:SLNO] saw its stock fall -1.59% to $85.27. Over the last five days, the stock has gained 2.43%. Soleno Therapeutics Inc shares have risen nearly 114.62% since the year began. Nevertheless, the stocks have risen 89.70% over the past one year. While a 52-week high of $87.16 was reached on 07/03/25, a 52-week low of $40.19 was recorded on 01/15/25.
Levels Of Support And Resistance For SLNO Stock
The 24-hour chart illustrates a support level at 84.14, which if violated will result in even more drops to 83.02. On the upside, there is a resistance level at 86.30. A further resistance level may holdings at 87.34.
How much short interest is there in Soleno Therapeutics Inc?
A steep rise in short interest was recorded in Soleno Therapeutics Inc stocks on 2025-06-13, dropping by 81206.0 shares to a total of 4.06 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-15 was 4.15 million shares. There was a decline of -2.0%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on September 03, 2024 when H.C. Wainwright began covering the stock and recommended ‘”a Buy”‘ rating along with a $70 price target.
